Has Rupesh Kotecha, MD received payments from drug or device companies?

Yes. Drug and device makers reported $208,456 in general payments to Rupesh Kotecha, MD across 218 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Rupesh Kotecha, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Rupesh Kotecha, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Rupesh Kotecha, MD

Radiation Oncology · Miami, FLNPI 1184990871

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (37.9%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Novocure Inc. at 50.3% of the total. Among radiation oncology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$208,456in general payments, 2019–2025

Across 218 payments — averaging $956.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novocure Inc.$105K
Elekta, Inc.$28K
Accuray Incorporated$27K
Viewray Technologies Inc$12K
GT Medical Technologies, Inc$9K
Elekta Instrument AB$8K
plus $20K from 14 others

$1,826,864in research payments, 2019–2025

Across 199 payments — averaging $9180.22 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Blue Earth Diagnostics$1.3M
Medtronic$237K
Novocure Inc.$133K
Viewray Technologies Inc$102K
Novocure GmbH$28K
Exelixis Inc.$27K
plus $15K from 1 others

What the payments were for

Consulting fees$74,81436%
Speaking & faculty fees$78,98238%
Travel & lodging$47,35323%
Food & beverage$6,8443%
Entertainment$4630%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novocure Inc.	93	$104,782
Elekta, Inc.	33	$27,672
Accuray Incorporated	16	$26,500
Viewray Technologies Inc	18	$12,317
GT Medical Technologies, Inc	19	$9,493
Elekta Instrument AB	5	$7,575
Novocure GmbH	5	$5,602
Servier Pharmaceuticals LLC	2	$4,772
Brainlab, Inc.	13	$2,601
Elekta Medical, S.A.	1	$2,319
Zap Surgical Systems, Inc.	2	$1,366
IBA Proton Therapy, Inc.	1	$1,108
Ion Beam Applications S.A.	2	$926
AstraZeneca	2	$627
Biogen	1	$558
Boehringer Ingelheim	1	$88
Siemens Medical Solutions USA, Inc.	1	$82
Varian Medical Systems, Inc.	1	$29
Blue Earth Diagnostics	1	$21
Bayer	1	$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ELEKTA MEDICAL LINEAR ACCELERATOR$51,982
Oncology$27,002
CyberKnife System$25,384
OPTUNE LUA (NOVOTTF-200T)$19,150
TomoTherapy System$12,342
MRIdian LINAC$10,341
GammaTile$9,441
NovoTTF-100L$9,391
Leksell Stereotactic System$8,413
ELEKTA UNITY$7,042
VANTAGE$5,123
MicroDrive$5,123
LEKSELL GAMMA KNIFE ICON$4,821
Optune$4,770
Optune Gio$4,527
Icon$3,303
LEKSELL GAMMA KNIFE PERFEXION$3,290
LEKSELL GAMMAPLAN$3,290
LEKSELL VANTAGE STEREOTACTIC SYSTEM$3,290
Clarity$2,900

How this compares

$208,456 in reported general payments places this provider in the 95th percentile of 465 radiation oncology providers in Florida.

See all radiation oncology providers in Florida →

Medicare billing

Part B allowed, 2024

$261,943

Medicare patients

285

Services billed

2,440

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other radiation oncology in Miami

Marcio FagundesMiami$274K
Michael ChuongMiami$152K
Marcus BredelMiami$64K
Minesh MehtaMiami$38K
Brandon MahalMiami$28K
Matthew AbramowitzMiami$23K
Ana BoteroMiami$21K
Alan Dal PraMiami$10K
Ahmed AklMiami$8K
Shravan KandulaOrlando$444K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →